| Mark W. Izard, M.d. P.c. | |
|
85 Seymour St. Suite 901 Hartford CT 06106-5528 | |
| (860) 246-8861 | |
| (860) 724-4858 |
| Full Name | Mark W. Izard, M.d. P.c. |
|---|---|
| Speciality | Internal Medicine |
| Location | 85 Seymour St., Hartford, Connecticut |
| Authorized Official Name and Position | Mark W. Izard (M.D./PRESIDENT) |
| Authorized Official Contact | 8602468861 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Mark W. Izard, M.d. P.c. 85 Seymour St. Suite 901 Hartford CT 06106-5528 Ph: (860) 246-8861 | Mark W. Izard, M.d. P.c. 85 Seymour St. Suite 901 Hartford CT 06106-5528 Ph: (860) 246-8861 |
| NPI Number | 1154554483 |
|---|---|
| Provider Enumeration Date | 09/03/2009 |
| Last Update Date | 12/11/2009 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154554483 | NPI | - | NPPES |
| 001101963 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 010196 (Connecticut) | Primary |
News Archive
CNN reports on how "the issue of forced abortions - and in some cases, forced sterilizations - in China has seized the spotlight in recent days with news of escaped activist Chen Guangcheng," who "rose to fame in the late 1990s because of his advocacy for what he calls victims of abusive practices, such as forced abortions, by Chinese family planning officials." China's so-called "one-child policy has been blamed for abuses," the news service reports.
Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.
More than 120 million Americans have joined arguably the most sought-after club on Earth: those immunized against the coronavirus.
Otsuka Pharmaceutical Co., Ltd. today announced it has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca (generic name: tolvaptan) has been approved in Japan in 7.5-mg and 15-mg tablet forms for extended use for the additional indication of ADPKD. Also, the new dosage form of 30-mg Samsca tablets has received approval for the indication of ADPKD.
› Verified 2 days ago
South Park Inn Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 21 Grand St, Hartford, CT 06106 Phone: 860-550-7500 | |
Trinity Health Of New England Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 114 Woodland St, Saint Francis Medical Group Inc., Hartford, CT 06105 Phone: 860-714-1325 Fax: 860-714-8078 | |
Connecticut Gi Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 85 Seymour St, 1000, Hartford, CT 06106 Phone: 860-246-2571 Fax: 860-246-3691 | |
Community Health Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 500 Albany Ave, Hartford, CT 06120 Phone: 860-249-9625 Fax: 860-808-1540 | |
Cleanslate Medical Group Of Connecticut Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 85 Gillett St, Hartford, CT 06105 Phone: 615-425-0220 Fax: 413-727-3619 | |
Robert E. Koorse Md Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1000 Asylum Ave, Suite 4303, Hartford, CT 06105 Phone: 860-524-5083 Fax: 860-524-5085 | |
Immaculate Conception Shelter Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 574 Park St, Hartford, CT 06106 Phone: 860-550-7500 |